<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001513'>Obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are emerging global epidemics associated with <z:hpo ids='HP_0011010'>chronic</z:hpo>, low-grade <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>A characteristic feature of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is <z:mp ids='MP_0002908'>delayed wound healing</z:mp>, which increases the risk of <z:hpo ids='HP_0002719'>recurrent infections</z:hpo>, tissue <z:mp ids='MP_0001651'>necrosis</z:mp>, and limb <z:mpath ids='MPATH_686'>amputation</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>In health, <z:mp ids='MP_0001845'>inflammation</z:mp> is actively resolved by endogenous mediators, such as the resolvins </plain></SENT>
<SENT sid="3" pm="."><plain>d-Series resolvins are generated from <z:chebi fb="0" ids="36005">docosahexaenoic acid</z:chebi> (DHA) and promote macrophage-mediated clearance of microbes and apoptotic cells </plain></SENT>
<SENT sid="4" pm="."><plain>However, it is not clear how type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> affects the resolution of <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Here, we report that resolution of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002586'>peritonitis</z:hpo> is delayed in <z:mp ids='MP_0001261'>obese</z:mp> diabetic (db/db) mice </plain></SENT>
<SENT sid="6" pm="."><plain>Altered resolution was associated with decreased apoptotic cell and Fc receptor-mediated macrophage clearance </plain></SENT>
<SENT sid="7" pm="."><plain>Treatment with resolvin D1 (RvD1) enhanced resolution of <z:hpo ids='HP_0002586'>peritonitis</z:hpo>, decreased accumulation of apoptotic thymocytes in diabetic mice, and stimulated diabetic macrophage phagocytosis </plain></SENT>
<SENT sid="8" pm="."><plain>Conversion of DHA to monohydroxydocosanoids, markers of resolvin biosynthesis, was attenuated in diabetic wounds, and local application of RvD1 accelerated wound closure and decreased accumulation of apoptotic cells and macrophages in the wounds </plain></SENT>
<SENT sid="9" pm="."><plain>These findings support the notion that <z:mp ids='MP_0002055'>diabetes</z:mp> impairs resolution of wound healing and demonstrate that stimulating resolution with proresolving <z:chebi fb="23" ids="18059">lipid</z:chebi> mediators could be a novel approach to treating <z:hpo ids='HP_0011010'>chronic</z:hpo>, nonhealing wounds in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>